These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2792664

  • 21. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.
    Lieverse RJ, Jansen JB, Masclee AA, Rovati LC, Lamers CB.
    Gut; 1994 Apr; 35(4):501-5. PubMed ID: 8174988
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effect of loxiglumide and atropine on erythromycin-induced reduction in gallbladder volume in human subjects.
    Jebbink MC, Masclee AA, van der Kleij FG, Schipper J, Rovati LC, Jansen JB, Lamers CB.
    Hepatology; 1992 Oct; 16(4):937-42. PubMed ID: 1398500
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Role of endogenously released cholecystokinin in determining postprandial insulin levels in man: effects of loxiglumide, a specific cholecystokinin receptor antagonist.
    Baum F, Nauck MA, Ebert R, Cantor P, Hoffmann G, Choudhury AR, Schmidt WE, Creutzfeldt W.
    Digestion; 1992 Oct; 53(3-4):189-99. PubMed ID: 1291406
    [Abstract] [Full Text] [Related]

  • 27. Cholecystokinin in the inhibition of gastric secretion and gastric emptying in humans.
    Konturek SJ, Kwiecien N, Obtulowicz W, Kopp B, Oleksy J, Rovati L.
    Digestion; 1990 Oct; 45(1):1-8. PubMed ID: 2340960
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effect of endogenous cholecystokinin on postprandial gallbladder refilling. Ultrasonographic study in healthy subjects and in gallstone patients.
    Cicala M, Corazziari E, Diacinti D, Badiali D, Torsoli A.
    Dig Dis Sci; 1995 Jan; 40(1):76-81. PubMed ID: 7821124
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humans.
    Zerbib F, Bruley Des Varannes S, Scarpignato C, Leray V, D'Amato M, Rozé C, Galmiche JP.
    Am J Physiol; 1998 Dec; 275(6):G1266-73. PubMed ID: 9843762
    [Abstract] [Full Text] [Related]

  • 32. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.
    Hildebrand P, Beglinger C, Gyr K, Jansen JB, Rovati LC, Zuercher M, Lamers CB, Setnikar I, Stalder GA.
    J Clin Invest; 1990 Mar; 85(3):640-6. PubMed ID: 2312719
    [Abstract] [Full Text] [Related]

  • 33. Effect of cholecystokinin-A receptor blockade on postprandial insulinaemia and gastric emptying in humans.
    Hidalgo L, Clavé P, Estorch M, Rodríguez-Espinosa J, Rovati L, Greeley GH, Capellà G, Lluís F.
    Neurogastroenterol Motil; 2002 Oct; 14(5):519-25. PubMed ID: 12358680
    [Abstract] [Full Text] [Related]

  • 34. Effects of CCK-receptor antagonist on colonic motor activity in dogs.
    Karaus M, Niederau C.
    Neurogastroenterol Motil; 1995 Jun; 7(2):63-71. PubMed ID: 7621322
    [Abstract] [Full Text] [Related]

  • 35. Anticholecystokinin activities of loxiglumide.
    Setnikar I, Bani M, Cereda R, Chisté R, Makovec F, Pacini MA, Revel L.
    Arzneimittelforschung; 1987 Oct; 37(10):1168-71. PubMed ID: 3435589
    [Abstract] [Full Text] [Related]

  • 36. The effect of loxiglumide (CR-1505) on basal and bombesin-stimulated gallbladder volume in man.
    Douglas BR, Jebbink MC, Tjon a Tham RT, Jansen JB, Lamers CB.
    Eur J Pharmacol; 1989 Jul 18; 166(2):307-9. PubMed ID: 2792196
    [Abstract] [Full Text] [Related]

  • 37. Cholecystokinin in the control of gastric acid secretion in humans.
    Konturek JW, Gutwinska-Konturek M, Gabryelewicz A, Konturek SJ, Domschke W.
    J Clin Gastroenterol; 1993 Jul 18; 17 Suppl 1():S40-5. PubMed ID: 7904286
    [Abstract] [Full Text] [Related]

  • 38. Cholecystokinin is a regulator of intestinal phase-stimulated PP release.
    Adler G, Beglinger C, Braun U, Reinshagen M, Koop I, Schafmayer A.
    Regul Pept; 1990 Sep 10; 30(2):105-11. PubMed ID: 2274676
    [Abstract] [Full Text] [Related]

  • 39. Endogenous cholecystokinin enhances postprandial gastroesophageal reflux in humans through extrasphincteric receptors.
    Clavé P, González A, Moreno A, López R, Farré A, Cussó X, D'Amato M, Azpiroz F, Lluís F.
    Gastroenterology; 1998 Sep 10; 115(3):597-604. PubMed ID: 9721157
    [Abstract] [Full Text] [Related]

  • 40. Long-term effects of CCK-agonist and -antagonist on food intake and body weight in Zucker lean and obese rats.
    Meereis-Schwanke K, Klonowski-Stumpe H, Herberg L, Niederau C.
    Peptides; 1998 Sep 10; 19(2):291-9. PubMed ID: 9493861
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.